Document Detail


COG1410, a novel apolipoprotein-E mimetic, improves functional and morphological recovery in a rat model of focal brain ischemia.
MedLine Citation:
PMID:  18803296     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Apolipoprotein E (apoE) is the primary apolipoprotein synthesized in the brain in response to injury with known neuroprotective effects exerted through antioxidant, antiinflammatory, antiexcitotoxic, and neurotrophic mechanisms. We have previously demonstrated that COG1410, an apoE mimetic peptide, exerts neuroprotective and antiinflammatory effects in a murine model of traumatic brain injury (TBI). As in TBI, ischemia-reperfusion injury is a component of acute stroke, which displays a pharmacogenetic association with the APOE4 gene. Using an intraluminal middle cerebral occlusion (MCAO) model in rats, we found that a single intravenous injection of COG1410 at 120 min post-MCAO significantly improved vestibulomotor function, decreased poststroke locomotor asymmetry, and decreased infarct volume of the ipsilateral hemisphere. These results support further exploration of a novel apoE-mimetic peptide, COG1410, as a therapeutic treatment for stroke.
Authors:
Elena A Tukhovskaya; Alexey Yu Yukin; Oksana N Khokhlova; Arkady N Murashev; Michael P Vitek
Related Documents :
10670416 - Neuroprotective effects of an ampa receptor antagonist ym872 in a rat transient middle ...
17678976 - Neuroprotective effect of nitroglycerin in a rodent model of ischemic stroke: evaluatio...
15466246 - A newly synthesized poly(adp-ribose) polymerase inhibitor, dr2313 [2-methyl-3,5,7,8-tet...
20691766 - Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke ...
6236336 - Influence of a reticuloendothelial-suppressing agent on liver tumor growth in the rat.
18826756 - Injection of muscimol, a gabaa agonist into the anterior thalamic nucleus, suppresses h...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Journal of neuroscience research     Volume:  87     ISSN:  1097-4547     ISO Abbreviation:  J. Neurosci. Res.     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-02-03     Completed Date:  2009-03-31     Revised Date:  2010-09-21    
Medline Journal Info:
Nlm Unique ID:  7600111     Medline TA:  J Neurosci Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  677-82     Citation Subset:  IM    
Copyright Information:
(c) 2008 Wiley-Liss, Inc.
Affiliation:
Branch of Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow Region, Russia. lenoktuk@rambler.ru
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Apolipoproteins E / administration & dosage,  therapeutic use*
Brain / blood supply,  drug effects,  pathology,  physiopathology
Disease Models, Animal
Infarction, Middle Cerebral Artery / drug therapy*,  physiopathology
Ketamine / pharmacology
Male
Motor Activity / drug effects*
Postural Balance / drug effects*
Rats
Rats, Sprague-Dawley
Grant Support
ID/Acronym/Agency:
AG 020473/AG/NIA NIH HHS; R44 AG020473-05/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Apolipoproteins E; 0/COG1410; 6740-88-1/Ketamine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence and correlates of traumatic brain injury among delinquent youths.
Next Document:  Vitreous humor and albumin augment the proliferation of cultured retinal precursor cells.